York research team recruits first patient to kidney disease study
The York renal research team have recruited the first patient in the UK to a worldwide study that focuses on patients who have anaemia caused by chronic kidney disease.
Anaemia commonly arises in patients with kidney dysfunction because the kidneys no longer produce sufficient amounts of a hormone which stimulates red blood cell production.
ASCEND-ND compares an investigational oral medication to the standard anaemia treatment which is currently an injection. Patients can be involved in the study for up to five years which involves regular study visits with the research team.
The renal research team would like to thank R&D, pharmacy, labs and the specialist anaemia team for their continued support with the study.